Trial
NCT02585622
NEPHSTROM for Diabetic Kidney Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Mario Negri Institute for Pharmacological Research
Collaborators
Leiden University Medical Center; Papa Giovanni XXIII Hospital; Istituto Di Ricerche Farmacologiche Mario Negri; Belfast Health and Social Care Trust; National University of Ireland, Galway, Ireland; University Hospital Birmingham NHS Foundation Trust; NHS Blood and Transplant
Condition
Diabetic Kidney Disease
Intervention
Mesenchymal Stromal Cells
Why stopped
IMP NEPHSTROM ORBECEL-M is expired and additional extension is not feasible. Low recruitment rate at Birmingham center.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-29